Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD Read more about Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD Read more about Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD
Differences in Pulmonary Function Improvement after Once-Daily LABA/LAMA Fixed-Dose Combinations in Patients with COPD Read more about Differences in Pulmonary Function Improvement after Once-Daily LABA/LAMA Fixed-Dose Combinations in Patients with COPD
SEREAL||Japan real world evidence supports sequential treatment with the use of upfront 2nd generation TKI Read more about SEREAL||Japan real world evidence supports sequential treatment with the use of upfront 2nd generation TKI
SEREAL||GioTag, the 1st global study to show feasibility of sequential therapy with GIOTRIF® followed by osimertinib Read more about SEREAL||GioTag, the 1st global study to show feasibility of sequential therapy with GIOTRIF® followed by osimertinib
Strategies to optimise the management of EGFR TKI-related side effects Read more about Strategies to optimise the management of EGFR TKI-related side effects
GIOTRIF® delays onset and risk of CNS progression in patients with or without brain metastases Read more about GIOTRIF® delays onset and risk of CNS progression in patients with or without brain metastases
GIOTRIF vs gefitinib 1st line treatment EGFRm NSCLC Read more about GIOTRIF vs gefitinib 1st line treatment EGFRm NSCLC
